Register for free
Recent Quotes
My Watchlist
Indicators
Business Insurance Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,025.28 +3.91 (+0.38%)
Official Closing Price Updated: 7:00 PM EST, Nov 14, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
News headline image
1 Undervalued Growth Stock Down 8% to Buy Before 2026 ↗
This momentary pullback represents an excellent opportunity to buy this high-flying stock. 
Via The Motley Fool
Topics World Trade
News headline image
Eli Lilly Partners With Nvidia To Build Pharma’s Most Powerful AI Supercomputer ↗
The Nvidia-powered system aims to cut drug development times and boost innovation. 
Via Talk Markets
Topics Artificial Intelligence
News headline image
Why Nvidia (NVDA) Stock Is Up Today
Shares of leading designer of graphics chips Nvidia (NASDAQ:NVDA) jumped 5.2% in the afternoon session after CEO Jensen Huang laid out an overwhelmingly bullish case for the company's future at a... 
Via StockStory
Topics Artificial Intelligence Government World Trade
News headline image
Ken Paxton Alleges Johnson & Johnson Misled Mothers On Tylenol Safety ↗
Texas Attorney General Ken Paxton sued Johnson & Johnson and Kenvue, alleging Tylenol was deceptively marketed as safe for pregnant women. 
Via Benzinga
Topics Lawsuit
Eli Lilly To Acquire Adverum Biotechnologies ↗
Via Stocktwits
News headline image
Why NeoGenomics (NEO) Stock Is Trading Up Today
Shares of oncology (cancer) diagnostics company NeoGenomics (NASDAQ:NEO) jumped 1.1% in the morning session after it reported third-quarter 2025 results where revenue beat Wall Street's expectations. 
Via StockStory
Topics World Trade
News headline image
If I Could Only Buy 2 Stocks in the Last Quarter of 2025, I'd Pick These ↗
These two have been neglected by Wall Street too much. 
Via The Motley Fool
News headline image
Eli Lilly & Co (NYSE:LLY) Presents a High Growth Momentum and Technical Breakout Opportunity ↗
Eli Lilly (LLY) is a top growth momentum stock with accelerating earnings, strong technical ratings, and a positive breakout setup for investors. 
Via Chartmill
News headline image
Healthcare Sector Navigates Volatile Waters as S&P 500 Closes: A Deep Dive into Key Market Drivers
As the closing bell rings on October 27, 2025, the S&P 500 Healthcare sector stands at a critical juncture, exhibiting the nuanced volatility that defines this essential yet complex segment of the... 
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
News headline image
Peering Into Eli Lilly and Co's Recent Short Interest ↗
 
Via Benzinga
News headline image
BDF-GESTION Trims Its Eli Lilly (LLY) Stake by 4,149 Shares ↗
BDF-GESTION Trims Its Eli Lilly (LLY) Stake by 4,149 Shares 
Via The Motley Fool
News headline image
What Is 1 of the Best Pharmaceutical Stocks to Buy Now? ↗
This pharma giant is entering the rapidly expanding market for weight loss drugs. 
Via The Motley Fool
News headline image
Down 15%, Should You Buy the Dip on Eli Lilly? ↗
Lilly's stock has pulled back from its 2024 highs, but that doesn't mean the shares are cheap enough to buy. 
Via The Motley Fool
Topics Intellectual Property
News headline image
Viking Therapeutics: High Risk, High Reward Play ↗
Via MarketBeat
News headline image
Should You Buy Eli Lilly Stock Before Oct. 30? ↗
Long-term investors don't need to rush to buy Eli Lilly stock. 
Via The Motley Fool
News headline image
Avidity Shareholders Win Big As Novartis Moves Fast On $12 Billion Deal ↗
Avidity Biosciences (NASDAQ: RNA) shares soar as Novartis (NYSE: NVS) agrees to acquire them for $12 billion in cash. 
Via Benzinga
News headline image
BioAge Labs Stock Just Soared. Does It Have More Fuel to Climb Higher? ↗
The clinical-stage biotech is working on a new type of weight management drug. 
Via The Motley Fool
News headline image
Eli Lilly And Co. Stock: Gains As $12.47-Per-Share Adverum Biotech Deal Expands Gene Therapy Portfolio ↗
Eli Lilly stock rises as $12.47-per-share Adverum Biotech deal boosts its gene therapy ambitions and expands ophthalmology pipeline. 
Via Talk Markets
News headline image
Eli Lilly's New Ebglyss Results Back Flexible Treatment Options For Atopic Dermatitis ↗
Eli Lilly reports new data showing sustained efficacy for Ebglyss with less frequent dosing and strong long-term results for Olumiant in hair regrowth. 
Via Benzinga
News headline image
Eli Lilly Bets Big On Eye Gene Therapy That Could End Repeat Injections ↗
Lilly (LLY) to acquire Adverum Biotechnologies (ADVM) for $12.47 per share, with potential CVR payments tied to future milestones. 
Via Benzinga
News headline image
Eli Lilly Options Trading: A Deep Dive into Market Sentiment ↗
 
Via Benzinga
News headline image
Mounjaro Maker Eli Lilly Jumps In Quality Despite Trump-Fueled Price Cut Fears ↗
Eli Lilly jumps to top 10% in quality rankings, showing strong fundamentals even as Trump pushes for weight loss drug price cuts in 2025. 
Via Benzinga
Topics Government
News headline image
2 Things Investors Should Know About Eli Lilly's $5 Billion Investment to Improve Its Drug Production Capacity ↗
Even aggressive tariffs may prove unable to stop this high-flying stock. 
Via The Motley Fool
Topics Government World Trade
News headline image
Cipla Shares Fall To Biggest Intra-day Lows In Six Months Despite Eli Lilly Deal For Diabetes Drug ↗
Cipla-Eli Lilly partner to distribute Tirzepatide under the Yurpeak brand in India 
Via Stocktwits
News headline image
Sensex, Nifty Poised For A Subdued Opening; HAL, BDL, Mazagon, Cipla, Colgate, Tata Motors, Kaynes Tech Stocks Are In Focus ↗
Midwest to list at 10 a.m. with GMP indicating a premium of ₹111 
Via Stocktwits
Topics World Trade
News headline image
WST Stock Soars After Company Raises Full-Year Guidance On Strong Demand For GLP-1 Drug Components ↗
The Pennsylvania-headquartered company raised its full-year net sales guidance to $3.06 billion to $3.07 billion, up from $3.04 billion to $3.06 billion. 
Via Stocktwits
Topics Artificial Intelligence Earnings
News headline image
2 Vanguard ETFs to Buy With $1,000 and Hold Forever ↗
These exchange-traded funds could be great complementary additions to your portfolio. 
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
News headline image
3 Pharmaceutical Growth Stocks to Buy and Hold for 10 Years ↗
Via MarketBeat
News headline image
Viking Bolts Higher On 'Lightning' Speed Enrollment In Obesity Studies ↗
Viking Therapeutics stock popped Thursday on the lightening pace it's enrolling patients in a pair of obesity treatment tests. 
Via Investor's Business Daily
News headline image
Eccogene Eyes Hong Kong IPO With Experimental Weight-Loss Drug, AstraZeneca Partnership ↗
 
Via Benzinga
Topics Initial Public Offering
< Previous 1 2 3 4 5 6 7 8 9
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.

Never miss important news. Subscribe to our newsletter.
Register for free

Information

Copyright 2024. BUSINESS INSURANCE HOLDINGS